NRX Pharmaceuticals, Inc. Repayments of Bank Debt
NRX Pharmaceuticals, Inc. (NRXP) reported Repayments of Bank Debt of $249.46 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfBankDebt · last filed 2020-11-16
- NRX Pharmaceuticals, Inc. repayments of bank debt for the quarter ending 2020-09-30 was $33.72K, a 79.46% decline year-over-year.
- NRX Pharmaceuticals, Inc. repayments of bank debt for the quarter ending 2020-06-30 was $23.22K.
- NRX Pharmaceuticals, Inc. repayments of bank debt for the quarter ending 2020-03-31 was $192.52K, a 72.10% decline year-over-year.
- NRX Pharmaceuticals, Inc. repayments of bank debt for the quarter ending 2019-09-30 was $164.15K.
| Period end | Repayments of Bank Debt 3 month | Repayments of Bank Debt 6 month | Repayments of Bank Debt 9 month |
|---|---|---|---|
| 2020-09-30 | $33.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $56.94K derived: sum of 2 quarters · filed 2020-11-16 | $249.46K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $23.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $215.74K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $192.52K 10-Q · filed 2020-05-15 | ||
| 2019-09-30 | $164.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $164.15K derived: sum of 2 quarters · filed 2020-11-16 | $854.15K 10-Q · filed 2020-11-16 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $690.00K 10-Q · filed 2020-08-14 | |
| 2019-03-31 | $690.00K 10-Q · filed 2020-05-15 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $0.00 10-Q · filed 2019-11-14 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $0.00 10-Q · filed 2019-08-14 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |